Last Price$1.7(7.7%)
Market Cap$85.9M
N/A
Industry median - 13.1%
5Y Historical average - N/A
68.8%
Industry median - 0.6%
5Y Historical average - 60.1%
29.9%
Industry median - (20.7%)
5Y Historical average - 9.0%
67.0%
Industry median - (1.5%)
5Y Historical average - 79.4%
CABA Growth Rating
CABA Growth rating
7.9
CABA Growth rating performance
CABA Growth Metrics
Annual
Quarterly
LTM
Industry Median
5Y Historical Average
Benchmark
Competing with CABA Growth
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name | Market Cap | Growth score | Revenue Growth
(5Y CAGR) | Revenue Growth
(YoY) | Revenue Growth
(FWD) | EPS Growth
(5Y CAGR) | EPS Growth
(YoY) | EPS Growth
(FWD) | FCF Growth
(5Y CAGR) | FCF Growth
(YoY) |
$85.9M | 7.9 | N/A | N/A | N/A | 12.6% | 29.9% | 41.7% | 51.4% | 67.0% | |
$402.0B | 7.6 | 18.9% | 25.0% | 19.9% | 6.7% | (17.3%) | 23.5% | 14.5% | 0.0% | |
$125.5B | 6.8 | 21.5% | 11.5% | 6.8% | N/A | N/A | (988.1%) | N/A | N/A | |
$74.0B | 5.5 | 12.6% | 8.3% | 3.4% | 16.1% | 10.3% | 9.5% | 12.5% | (5.7%) | |
$38.1B | 6.2 | 106.9% | 127.3% | 76.7% | (9.7%) | (57.5%) | (141.9%) | N/A | (70.8%) | |
$31.3B | 5.4 | 59.2% | 23.0% | 16.9% | (23.2%) | (38.5%) | (55.3%) | (36.7%) | N/A | |
$27.1B | 6.1 | 83.9% | (54.1%) | (28.2%) | 29.6% | N/A | (182.9%) | N/A | (79.0%) | |
$14.8B | 3.8 | 14.5% | 14.8% | 9.3% | (35.1%) | (91.0%) | 3,612.9% | (18.0%) | (47.6%) | |
$14.6B | 5.7 | (100.0%) | N/A | N/A | (7.1%) | (94.8%) | 6.8% | 44.6% | 84.8% | |
$14.0B | 7.5 | 14.7% | 23.6% | 10.7% | N/A | 25.6% | 9.9% | N/A | 44.5% | |
$1,846.9M | 5.0 | 50.5% | 50.5% | 50.7% | (11.2%) | (16.6%) | (35.6%) | 2.7% | (45.5%) |
FAQ
What is the Cabaletta Bio, Inc. (CABA) revenue growth?
The Cabaletta Bio, Inc. (CABA) revenue growth is N/A, which is lower than the industry median of 13.1% and the 5-year historical average of N/A.
What is the Cabaletta Bio, Inc. (CABA) operating income growth?
The Cabaletta Bio, Inc. (CABA) operating income growth is 68.8%, compared to the industry median of 0.6% and the 5-year historical average of 60.1%.
What is the Cabaletta Bio, Inc. (CABA) EPS (Earnings Per Share) growth?
The Cabaletta Bio, Inc. (CABA) EPS growth is 29.9%, compared to the industry median of (20.7%) and the 5-year historical average of 9.0%.
What is the Cabaletta Bio, Inc. (CABA) Free Cash Flow (FCF) growth?
The Cabaletta Bio, Inc. (CABA) Free Cash Flow growth is 67.0%, compared to the industry median of (1.5%) and the 5-year historical average of 79.4%.